| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.16 | 0.6 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.05 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.1 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.1 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.06 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.099 | 0.02 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.085 | 0.1 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.083 | 0.1 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.083 | 0.3 |